| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $225.39M | $156.37M | $130.55M | $189.49M | – |
| R&D | $194.69M | $129.84M | $105.58M | $51.86M | $13.28M |
| SG&A | $30.69M | $26.53M | $23.10M | $32.86M | $6.10M |
| Operating Income | -$225.39M | -$156.37M | -$130.55M | -$189.49M | -$6.10M |
| Interest Expense | $10.14M | $3.66M | $252.00K | $0.00 | $0.00 |
| Tax Expense | $1.01M | $507.00K | $1.57M | $932.98K | $0.00 |
| Net Income | -$224.25M | -$138.17M | -$127.66M | -$174.03M | $14.52M |
| EPS (basic) | -0.7000 | -0.4800 | -0.4600 | -0.6800 | -0.0800 |
| EPS (diluted) | -0.7000 | -0.4800 | -0.4600 | -0.6800 | -0.0800 |
| Shares (diluted) | $321.35M | $288.52M | $275.76M | $254.13M | $220.00M |